Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Decision Diagnostics Corp (OTC: DECN) -- Ignore unavailable to you. Want to Upgrade?

To: NAG1 who wrote (178)	2/25/2016 8:45:22 AM
From: thomas a. burke	Read Replies (2) \| Respond to of 267

Question for Neal, Pogue, ACAN or anyone else who may be following this company. I am curious as to what your theories are regarding the continuous selling pressure over the last few years? Traders shaving fractions of pennies, naked shorts or dilution? IMO, the O/S is well north of 100M and may even be approaching 200M shares. This may not be all bad though. If the company is truly going to take a shot at being a viable operating company in the diabetic testing market, then they may be able to generate revenues that would support them increasing the O/S by such an amount. However, if their business plan is strictly the litigation against J&J, then the small shareholder is probably screwed. By all accounts, the legal proceedings are going very well. Unfortunately, they could go on a lot longer and/or the financial returns could be much less than expected. Would like to hear what the rest of you think. Thanks. Tom